Delivery Order SPE2DB20D2014-SPE2DB25FB71L
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $31,119.15, is a delivery order for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price pricing type and runs through June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,963.62, is for the delivery of the medication Dupixent 300 mg/2 ml pen, with a completion date of April 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,039.26, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product, with a ceiling value of $12,634.70. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 16, 2025. The contract is not set aside and is open to competition....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $24,188.15 for the supply of Dupixent 300 mg/2 ml pen medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 19, 2023. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,146.60, is for the delivery of 4,567,137,177 units of Dupixent 300 mg/2 ml pen. The contract has a period of performance through February 4, 2025 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,240.34, is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Dupixent 300 mg/2 ml pen, a specialty medication, with a ceiling value of $16,917.34 and a performance period through July 2024. The contract is a Firm Fixed Price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $13,845.95 and a completion date of December 12, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...